Law
Fall 2016
Vol. 24, no. 1

Health Care

N E W S L E T T E R

Professor Frank Pasquale – Challenging
Conventional Wisdom and Changing the Narrative
on the Future of the U.S. Health Care System
When Professor Frank Pasquale
joined the Maryland Carey
Law faculty in 2013, the U.S.
was on the verge of launching
major data-sharing initiatives to
implement the Affordable Care
Act. At that time, in a previous
edition of this newsletter, Pasquale
warned that new and rapidly
changing technologies held
both promise and peril for the
health care industry. Now, three
years later, the Affordable Care
Act has transformed all sectors
of the health care industry and
Pasquale’s message is still the
same, if slightly more urgent, and
decision makers are listening. In
Professor Frank Pasquale
July 2016, at the White Housesponsored Artificial Intelligence
Now conference which convened leading thinkers on robotics law and
policy, Pasquale gave a talk on automation in health care. In the talk, he
warned about problems likely to be caused if robots prematurely replace the
work of humans. A recording of Pasquale’s talk is available at http://ainow.
staging.mysociety.org/schedule/conference/presentation/complementaryvs-substitutive-automation-healthcar. This high profile talk capped a year of
speaking and writing on cutting edge topics in health information law and
policy, including talks at the Food and Drug Administration, the European
Medicines Agency, and the London School of Economics (with the head of
NHS Digital, Britain’s leading health data authority).
On April 6-7, 2017, Pasquale will be hosting a roundtable at Maryland
Carey Law that focuses on automation in health care called “The Future
of Automation, Clinical Decision Support, and Robotics in Health Law &
Policy.” The by-invitation roundtable will bring together thought leaders
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Symposium
The Future of Automation, Clinical
Decision Support, and Robotics in
Health Law & Policy
April 7, 2017, Maryland Carey
Symposium Topics
• How do stakeholders assure data quality given increasing
demands on the time of providers?
• What are best practices for assuring privacy when innovations
like cloud robotics could lead to constant real-time monitoring
of patients?
• How should learning health care systems and predictive
analytics programs be audited for quality and reliability?
• Are “care robots” a practical solution to the aging of the baby
boomers, or an oxymoron?
• Will certain forms of sophisticated data analysis become the
“standard of care?” Should they?
• Do current or future payment models bias the development of
technology in certain directions?
• What is the potential for data-driven health care to curb or
exacerbate health disparities?
• Can black box medicine, such as machine learning that cannot
be reverse engineered or otherwise understood by humans,
offer valid clinical decision support? Should versions of it be
made available to consumers as apps?

in health technology and law to consider regulatory issues raised by
the rise of population health management, predictive analytics, and
robotics. Each field raises fundamentally new issues with respect to
data management and privacy, liability, and reimbursement.
The roundtable will include participant experts in the fields of
electronic health records, clinical decision support, and robotics.
To kick off the roundtable, renowned expert in health information
technology, Nicolas P. Terry, will serve as the law school’s Rome
Lecturer on Thursday, April 6 at 5pm in the Ceremonial Moot Court
Room. Professor Terry is the Hall Render Professor of Law and
Executive Director of the William S. and Christine S. Hall Center for
Law and Health at Indiana University’s Robert H. McKinney School of
Law. The lecture is open to the public.
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The roundtable will be an opportunity for Pasquale
to engage stakeholders in robust discussions on the
topics that he has been writing and lecturing about
in the last few years—and to sound the warning
bell regarding premature automation of critical
tasks. Machines are edging out the human worker
with many potential consequences, including mass
unemployment. But there are bright spots as machines
evolve. Pasquale suggests that robotics or software
are not just beneficial, but potentially lifesaving,
replacing humans “for dangerous or degrading work.”
Technological innovations can help collect trash or
remediate sites contaminated by nuclear radiation,
for example. But automating health industry jobs
such as providing care and counseling patients and
their families raises different questions entirely. For
example, one company has already developed a baby
seal robot to comfort patients in hospitals and nursing
homes.

Paro the Robo-Seal, a therapeutic robot baby seal to calm
patients in hospitals and nursing homes

The current push for automation is a call-to-action
for regulators, according to Pasquale: “Retarding
automation that controls, stigmatizes and cheats
innocent people is a vital role for 21st century
regulators.” Using automation to slash prices
should not be the primary goal of this new era of
technology, Pasquale cautions, because it is too
easy for automation’s proponents to change and
radically simplify tasks and then declare their work
done. Maintaining and improving quality are just as
important as cost cutting. Pasquale is under contract
with Harvard University Press to publish a book on
this topic called “Humane Automation: The Future
Logic of Professionalism” in 2018.
Pasquale’s book will discuss the impact of
automation on a number of professions, including

medicine. Pasquale believes that medicine is moving
forward with automation on the assumption that much
of what doctors do is algorithmic and that much of the
work of health care is matching a set of symptoms to
an optimal cure or treatment—a pattern recognition
problem ideally suited to machine learning. Although
recognizing the promise of automation to improve
health outcomes, particularly in the developing
world, Pasquale is urgently asking policy makers to
understand that medicine’s new wave of big data and
predictive analytics could mislead patients, erode
physicians’ skills, and subject the most vulnerable
patients to “cookbook medicine” that fails to respect
their values or interests, to the extent it replaces (rather
than complements) the work of qualified professionals.
Pasquale believes that, at present, software doesn’t
have the “spontaneity, creativity, flexibility, and
perceptiveness that are the hallmarks of skilled
doctors and nurses.” While some areas of medicine,
such as monitoring drug interactions are appropriate
for automation, some areas clearly are not. And even
automated clinical decision support for drug-drug
interactions has created a problem of “alert fatigue,”
which technologists and policymakers have yet to
solve. When it comes to end of life care, Pasquale
notes, easing the anxiety and suffering of others
requires a human touch. The idea of mapping out
every possibility in advance, and mechanizing the
termination of treatment, should alarm anyone with
personal or professional experience in an intensive
care unit, nursing home, or hospice. The stakes are
so high, the concept of quality of life so personal and
ineffable, the decision-making so properly shared
among family and providers, that algorithms should
only aid around the edges. Pasquale will be presenting
his work at a conference at Princeton this December
organized by Paul Starr (author of The Transformation
of American Health Care).
Cautiously developing technology to improve the
field of medicine while preserving the humanity of
providing care will certainly cost money and time,
according to Pasquale. “As professionals grapple
with new forms of advice and support based on
software and robots, they deserve laws and policies
designed to democratize opportunities for productivity
and autonomy,” he says. As implementation of
the Affordable Care Act moves forward, Pasquale
is clear that the cost-savings anticipated under the
Act and future legislation must not create such an
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administrative and technological burden for physicians
that current and future providers leave the field.
The risks of cost-cutting in health care was
addressed in Pasquale’s 2015 article, “The Hidden
Costs of Health Care Cost-Cutting: Toward a
Postneoliberal Health-Reform Agenda” in Duke Law
School’s Law and Contemporary Problems (77 Law
& Contemporary Problems 171-193 (2015)). In the
article he states that beneath the superficial consensus
that “health care is too expensive,” there are raging
debates on strategies of cost containment with some
favoring supply-side limits by reducing the quantity
or price of providers and others focusing on the
demand side and reducing expenditures on health care.
Others support the “quality movement” and believe
costs can be reduced by shifting spending to effective
interventions. But Pasquale thinks policymakers need
to take an urgent step back and ask the basic question
—how much should our society spend on health
care? The article provides a rationale for why this
question must be answered before policymakers point
to high health care spending in itself as a rationale
for reducing the purchasing power of patients,
reducing compensation of physicians, nurses, and
other providers, or deterring investment in hospitals,
drugs, and devices. While there is a clear case for
redistributing funds within the health sector from less
to more effective forms of care, we should not be
quick to assume that shrinking the sector would lead
to more productive spending in other areas.
In a recent post on Technology, Academics, Policy
(TAP) Blog, Pasquale refined the themes he discussed
at the White House AI Now Conference and in his
Duke article. In the blog he discusses the pushback
he got after the conference. Even if complementary
automation is better now, his critics asked “Shouldn’t
our policy reward firms that try to eliminate ever more
labor costs? Doesn’t everyone agree that the U.S.
spends too much on health care—and isn’t technology
the best way of reducing that spending?” His blog
post summarized his view that health economists
need to offer a “positive industrial policy on where
health spending should be going” rather than simply
support austerity in health care spending without a
foundational understanding of how spending should
look.
Pasquale’s work goes beyond health care professions
and focuses on automation in other professions as

well, including the law. Last year he published a
short article in the UCLA Law Review Discourse
titled “Four Futures of Legal Automation,” (63
UCLA L. Rev. Disc. 28 (2015), co-authored with
computer programmer Glyn Cashwell) that discusses
how automation will affect the future of the legal
profession. In addition, Pasquale recently published
two reviews of books that discuss the advance of
automation: The Future of the Professions by Richard
and Daniel Susskind in the L.A. Review of Books
(March 15, 2016) and The Second Machine Age:
Work, Progress, and Prosperity in a Time of Brilliant
Technologies by Erik Brynjolfsson and Andrew
McAfee’s in Boundary 2’s online edition (January 20,
2015).
In addition to his scholarship on automation and
the professions, Pasquale devotes time each week
to examine broader developments in the field in
his podcast, The Week in Health Law. Pasquale has
produced nearly 70 episodes of the podcast with his
co-host Professor Nicolas Terry. Recent topics of the
podcast have included the Affordable Care Act and its
impact on insurers, the ways health care is failing the
obese, ransomware and its effect on the health care
industry, drug pricing, and bioethics in reproductive
technology development. Recently, for Episode
67, Pasquale and Terry had former L&HCP student
Ameet Sarpatwari ’13 on the podcast. Sarpatwari is
now an instructor in medicine at Harvard Medical
School and an associate epidemiologist with Brigham
and Women’s Hospital. (See p. 5 for more about
Sarpatwari.) The podcast focused on the effects of
laws and regulations on therapeutic drug development,
approval, use, and related public health outcomes. The
podcast is available on iTunes and Google Play Music.
Pasquale has also published several pieces addressing
other issues in health law and policy over the past
year. They include Reforming the Law of Reputation
which addresses cutting edge challenges to health
privacy caused by hacking and republication of
breached medical records and Health Information
Law, a chapter in The Oxford Handbook of American
Health Law—which convened thought leaders in
health law and policy to write about topics for which
they are recognized experts. He is presently working
on a piece exploring the privacy implications of
corporate wellness programs.
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Law & Health Care Program Alums in Academia
The Law & Health Care Program at the University
of Maryland Francis King Carey School of Law aims
to prepare its students for any number of careers, and
several recent graduates have gone on to distinguish
themselves in the field of academia.
Ameet Sarpatwari, PhD, JD, graduated from the
School of Law with the Certificate in Health Law in
2013. Upon graduation, he was awarded the Joseph
Bernstein Award for the most significant student piece
of scholarly writing in health law. He now works as
an instructor in medicine at Harvard Medical School
and an associate epidemiologist with Brigham and
Women’s Hospital. He also serves as assistant director
for the Program On Regulation, Therapeutics, And
Law (PORTAL) at the hospital and teaches public

health law at the Harvard T.H. Chan School of Public
Health.
Sarpatwari studies pharmaceutical policy issues
such as the rising cost of prescription drugs and the
U.S. Food and Drug Administration’s post-approval
safety and effectiveness monitoring systems. A list of
his recent publications are provided in the box below.
Sarpatwari says he is currently working on developing
ethical norms for the effective and equitable use of
a particular safety program—risk evaluation and
mitigation strategies (REMS) with elements to assure
safe use—based on epidemiological investigations
and focused interviews with patients, physicians, and
regulators.

Cont. on page 6

Ameet Sarpatwari: Selected Publications
• Kesselheim AS, Avorn J, Sarpatwari A. “The high cost
of prescription drugs in the United States: origins and
prospects for reform.” JAMA. 2016;316(8):858-71.
• Sarpatwari A, Avorn J, Kesselheim AS. “State
initiatives to control medication costs—can
transparency legislation help?” N Engl J Med.
2016;374(24):2301-4.
• Sarpatwari A, Avorn J, Kesselheim AS. “Progress
and hurdles for follow-on biologics.” N Engl J Med.
2015;372(25):2380-82.
• Sarpatwari A, Kesselheim AS. “The case for
reforming drug naming: should brand name trademark
protections expire upon generic entry.” PLoS Med.
Ameet Sarpatwari ’13
2016;13(2):e1001955.
• Kesselheim AS, Avorn J, Sarpatwari A. “The high cost of prescription drugs in the United States:
origins and prospects for reform.” JAMA. 2016;316(8):858-71.
• Sarpatwari A, Choudhry NK, Avorn J, Kesselheim AS. “Paying physicians to prescribe generic drug
and follow-on biologics in the United States.” PLoS Med. 2015;12(3):e1001802.
• Darrow JJ, Sarpatwari A, Avorn J, Kesselheim AS. “Practical, legal, and ethical issues in expanded
access to investigational drugs.” N Engl J Med. 2015;372(3):279-86.
• Sarpatwari A, Franklin JM, Avorn J, Seeger JD, Landon JE, Kesselheim AS. “Are risk evaluation
and mitigation strategies associated with less off-label use of medications? The case of ITP.” Clin
Pharmacol Ther. 2015;97(2):186-93.
• Sarpatwari A, Kesselheim AS, Malin B, Gagne JJ, Schneeweiss S. “Ensuring patient privacy in data
sharing for postapproval research.” N Engl J Med. 2014;371(17):1644-49.
• Sarpatwari A, Avorn J, Kesselheim AS. “Using a drug-safety tool to prevent competition.” N Engl J
Med. 2014;370(16):1476-78.
• Sarpatwari A, Robertson CT, Yokum DV, Joiner K. “Crowdsourcing public health experiments: a
response to Jonathan Darrow’s ‘Crowdsourcing Clinical Trials’.” Minn. Law Rev. 2014;98:101-20.
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When asked about how his law school experience
is relevant to what he is doing now, Sarpatwari
responded that “[t]he stellar faculty” at Maryland
Carey Law helped to prepare him for his career.
“Having the chance to learn from some dynamic
scholars, particularly Richard Boldt, JD, and Rena
Steinzor, JD, was invaluable. The one-on-one
interaction, outside of class—you don’t get that
elsewhere.”
Sarpatwari also valued his “field experience,”
including an internship working with Marjorie Cook
Professor of Law Karen Rothenberg, JD, MPA, on her
bioethics research at the National Institutes of Health
(NIH). He also worked with Ellen Weber, JD, in the
Drug Policy Clinic that she founded at Maryland
Carey Law, helping to draft and advocate for a
Maryland law that increased access to naloxone, an
opioid overdose antidote.

Maryland Carey Law’s L&HCP also helped launch
another recent graduate into a career in academia.
Since earning his law degree and the Certificate in
Health Law in 2011, Michael Ulrich, JD, MPH,
has worked at the University of Maryland Center for
Health & Homeland Security, earned his master’s at
the Harvard School of Public Health, worked at the
National Institute of Allergy and Infectious Diseases’
Division of AIDS and just completed a two-year
fellowship at Yale Law School working with Abbe
Gluck, professor of law and faculty director of the
Solomon Center for Health Law and Policy. In each
of these positions, Ulrich managed to publish several
articles. Writing, he says, is a passion. Evidence of this
is the list of articles he has published since graduating.
This fall Ulrich begins a new position as an assistant
professor of health law, policy and management at the
Boston University School of Public Health.

Michael Ulrich: Selected Publications

Michael Ulrich ’11

• Ulrich M. “Law and Politics, an Emerging Epidemic: A Call for
Evidence-Based Public Health Law.” American Journal of Law &
Medicine. 42 (2016): 256-283.
• Ulrich M (with others). “Lincoln’s Promise: Congress, Veterans, and
Traumatic Brain Injury." Hastings Center Bioethics Forum (2016).
• Ulrich M. “Challenges for People With Disabilities Within the Health
Care Safety Net.” 15 Yale Journal of Health Policy, Law, and Ethics
247 (2015).
• Ulrich M. "The Impact of Law on the Right to Water and Adding
Normative Change to the Global Agenda.” 48 George Washington
International Law Review 43 (2015).
• Ulrich M. “Guidance From Vaccination Jurisprudence.” 13 American
Journal of Bioethics 40 (2013).

• Ulrich M. “The Duty to Rescue in Genomic Research.” 13 American Journal of Bioethics 50 (2013).
• Ulrich M. “With Child, Without Rights?: Restoring a Pregnant Woman’s Right to Refuse Medical
Treatment Through the HIV Lens.” 24 Yale Journal of Law and Feminism 303 (2012).
• Ulrich M. “Resource Restraints: Rethinking Disclosure of Individual Genomic Findings.” 128
Michigan State University Journal of Medicine and Law 127 (2012).
• Ulrich M. “Researchers Without Borders?: Limiting Obligations of Ancillary Care Through the
Rescue Model.” Vanderbilt Law School Health Law and Public Policy Forum (2011).
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Ulrich said there is no question what inspired him
to join academia—the faculty in the Law & Health
Care Program at Maryland Carey Law. “What helped
me the most was the open door policy that every
professor had,” Ulrich said. “I loved the professors’
willingness to go above and beyond. With my papers,
they would go through the issues with me, and
suggest what to read, and go over my research. That’s
really what drew me to the teaching part of academia.
It was such a huge benefit and added so much to
my learning experience. I wanted to provide that for

students by teaching.”
Ulrich began his academic career speaking at the
39th Annual Health Law Professors Conference held
this year at Boston University (BU) School of Law.
Ulrich’s talk was titled, “The Right to Bear Arms:
A Pubic Health Law Approach.” Ulrich will begin
at BU by teaching a health law policy course this
fall. He will also continue writing about gun rights
and applying public health law doctrine to second
amendment rights.

Health Law Student Attends Seton Hall Law Healthcare
Compliance Certification Program

Hillary Cleckler (3L) was awarded a
scholarship to attend Seton Hall Law’s Healthcare
Compliance Certification Program in June—the
fourth Maryland Carey Law student to win the
scholarship in the last several years. Cleckler,
who graduated from University of Michigan with
an undergraduate degree in English, applied for
the scholarship to learn more about a field into
which she has already made significant inroads.
Last Spring, Cleckler externed at the Office of
Chief Counsel to the Inspector General of HHS
doing health care fraud and abuse work. After
the compliance program in June, Cleckler spent
the rest of the summer clerking at the inhouse
counsel’s office at the University of Maryland
Health Care System.
Cleckler was grateful for the opportunity to
attend the compliance program saying “I learned
so much while I was there, especially about laws
I hadn't encountered thus far such as the FCPA
and the Sunshine Act and got to meet people
who have extensive experience in healthcare
compliance.” In this final year of law school,
Cleckler is busy as the President of the Student
Health Law Organization and an editor on the
Maryland Law Review.
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Hillary Cleckler (3L)

Microbiome Transplantation Project Updates
In June 2015, Director of the L&HCP Diane
Hoffmann was awarded an NIH grant to study
the legal and regulatory aspects of a cutting edge
medical treatment called microbiota transplantation.
The most commonly known form of microbiota
transplantation is the fecal microbiota transplantation
(FMT) to treat C. Difficile infection, but the project
is also looking at how to regulate other uses of FMT
as well as other emerging microbiota transplantation
options including vaginal, skin, anterior nares, oral,
and whole body transplants. See prior story about
the grant in the Fall 2015 L&HCP newsletter. The
Working Group of stakeholders convened under the
grant met for the first time on December 3-4, 2015 and
for the second time on May 2-3, 2016. The working
group will meet for the last time on December 1213, 2016, at the Maryland Carey Law to discuss final
recommendations to include in a project white paper.
Project Updates
• On September 8, Hoffmann attended a one-day
meeting of leading thinkers in microbiome-based
research and in compassionate use hosted by
Professor Arthur Caplan, founding Director of
the Division of Medical Ethics at the New York
University Langone Medical Center (NYULMC)
and the founder of the NYULMC Working Group
on Compassionate Use and Pre-Approval Access.
The Compassionate Use Working Group studies
issues relating to patients seeking access to
therapies that have not received FDA approval but
are in clinical trials. Professor Caplan organized
the FMT meeting because of the parallels between
patient requests for compassionate use exceptions
for unapproved drugs and patients seeking access
to fecal-based treatments for indications for which
there is no supporting efficacy and safety data.
The goal of the meeting was to bring together
experts whose experience would be helpful to
those in the field who are thinking through how to
respond to such requests from patients.
• On May 31, Hoffmann and her co-investigators
submitted formal comments to FDA on
FDA’s “Draft Guidance for Industry (FDA2013-D-0811-0022): Enforcement Policy
Regarding Investigational New Drug
Requirements for Use of Fecal Microbiota
for Transplantation to Treat Clostridium

difficile Infection Not Responsive to Standard
Therapies.” The comments informed FDA of
the work of Hoffmann’s grant-funded working
group to date, noting that the comments
to FDA were premised on the concept that
“regulating FMT requires a framework that
balances patient safety with the need to provide
appropriate access to the procedure and one
that does not unduly discourage research on the
effectiveness of microbiota transplantations.”
The co-investigators also commented on FDA’s
regulation of FMT to date, specific aspects of the
draft guidance including whether the traditional
Investigational New Drug (IND) process is
wholly appropriate for FMT, and whether
certain IND requirements should be modified or
waived for microbiota transplantation.
• Hoffmann and her co-investigators have
submitted an article for publication in a
forthcoming issue of the journal of Gut Microbes
titled “Commentary: A Proposed Definition
of Microbiota Transplantation for regulatory
purposes.” The commentary fills a vacuum
in the regulatory discussion of microbiota
transplantation which has proceeded to date
without an accepted definition of microbiota
transplantation from FDA or any other source.
The commentary sets forth a definition based on
working group discussion and co-investigator
research. The article also highlights the critical
need for a definition to guide how microbiota
transplantation should be regulated because the
definition of a product or process is often pivotal
in determining which FDA regulatory pathway
the product or process will traverse.
The other co-investigators on this project are Dr.
Frank Palumbo, Center on Drugs and Public Policy,
University of Maryland School of Pharmacy, Dr.
Jacques Ravel, Institute for Genome Sciences,
University of Maryland School of Medicine,
Dr. Mary-Claire Roghmann, Department of
Epidemiology and Public Health, University
of Maryland School of Medicine, Dr. Erik von
Rosenvinge, Division of Gastroenterology, University
of Maryland School of Medicine and Veterans
Affairs Maryland Health Care System and Virginia
Rowthorn, Law & Health Care Program, University
of Maryland Carey School of Law.
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Local Health Care Organizations Create
New Business Fellowships

Evergreen Health Co-op

When the call went out to identify businesses to
engage in Maryland Carey Law’s new Business
Fellowship Program, local health care organizations
and alumni of the Law & Health Care Program were
among the first to respond. The program places
law students and recent graduates in Baltimorearea businesses to help Maryland companies and
institutions meet their business and legal needs
while providing growth opportunities for the next
generation of law and business leaders. The program
supports 10-week Summer Fellowships and yearlong Postgraduate Fellowships. The University of
Maryland Medical System (UMMS), FutureCare,
LifeBridge Health, Evergreen Health, and Vasoptic
Medical Inc. were among the inaugural fellowship
partners offering paid placements to students. The
program’s postgraduate business fellowships are open
to new Maryland Carey Law alumni who work for 12
months working in the legal and business departments
of the organizations. According to Maryland Carey
Law's Office of Career Development, after the first
year of the program, employer organizations reported
that they were extremely impressed with the work of

their fellows and the law school received extremely
positive feedback from the selected students.
Jaclyn Machometa ’15 spent her first year out of law
school as a fellow in the Office of General Counsel
at UMMS where she gained invaluable legal drafting
experience in various health law matters including
physician contracting, corporate transactions,
corporate creation/structuring, guardianships, and
affiliation and vendor agreements. She said of the
Fellowship Program, “It was the perfect opportunity
for me to gain hands on experience in the fields of
both health and business law, two areas in which I
hope to establish a successful law career.” Vince
Andrews, a 2016 graduate of the Law & Health Care
Program, is the organization’s current fellow.
Reena Palanival (3L) spent her summer as a
fellow at Vasoptic Medical Inc., a company that
is developing a low-cost, easy-to-use, portable
retinal imager designed to non-invasively capture
physiological information from the retina. This
approach eliminates the need for pupil dilation or
contrast dyes and allows for important eye exams to
be performed in primary care and community care
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environments to increase access to eye exams for
at-risk and underserved populations. Vasoptic was
started by L&HCP alum M. Jason Brooke (see Fall
2015 L&HCP newsletter) who rose to the challenge
of creating a Fellowship opportunity to provide
hands-on legal and business expertise to students.
At her placement, Palanivel analyzed agreements
for consistency and critical provisions relevant to
the business operations, reviewed and summarized
patent related prior art, researched and analyzed
reimbursement policies related to retinal imaging, and
drafted standard operating procedures for compliance
with FDA regulations. She said of her time in the
Fellowship that it was not only invaluable in providing
her with experience in the interplay between health
and business, but also professionally enriching,
providing her with lifelong mentors.

L&HCP graduate Maryann Hong ’16 is currently a
postgraduate fellow at Evergreen Health, Maryland’s
only Health Care Cooperative, a member-driven
company created under the Affordable Care Act as
an innovative way to provide health insurance. One
of Evergreen Health’s attorneys is L&HCP alum,
Elliott Hooper ’13, who was instrumental in bringing
Evergreen to the Business Fellowship Program. Of
the Program, Hooper says the opportunity to partner
with Maryland Carey Law and the L&HCP was
particularly enticing to Evergreen Health. Evergreen
Health was drawn to the Fellowship Program by the
academic strength of Maryland Carey Law students
and the well-versed background in health law students
receive from the L&HCP. Evergreen Health felt the
academic strength of the L&HCP would prepare
fellows to actively contribute in a meaningful way
from the outset of their fellowship.

Maryland Carey Law Faculty Speak at Annual Health Law
Professors Meeting
Several Law & Health Care Program faculty members spoke at the 39th Annual Health Law Professors
Conference in June. The conference was co-sponsored by the American Society of Law, Medicine &
Ethics, Boston University School of Law, and Boston University School of Public Health.
Preeti Emrick, University of Maryland Center for Health and Homeland Security and University of
Maryland Law School, U.S. Public Health Law: Archaic or Relevant in the Context of Ebola?
Diane Hoffmann, University of Maryland Law School, Microbiota-Related Therapies and the Challenges
They Create for FDA
Leslie Meltzer Henry, University of Maryland Law School, Conducting Research with Pregnant Women:
Ethical and Legal Challenges in the Zika Pandemic
Frank Pasquale, University of Maryland Law School, Data Acquisition and Consent in Learning Health
Care Systems
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Professor Kathleen Hoke Brings Together Public Health
Stakeholders Around Complex Health Issues
Hoke noted that “since its inception in 2001, the
LRC has worked to assist state and local public health
officials to address the devastating impact of exposure
to secondhand smoke, with a particular focus on
vulnerable populations, such as youth, senior citizens,
and those with chronic illnesses.”
The LRC assisted with gaining passage of the
2007 Maryland Clean Indoor Air Act and related
regulations, securing protections for hospitality
workers who had been carved out of protections when
other workplaces were rendered smoke-free in 1992.
“Seeking these same protections for those exposed in
public housing was a natural extension of these earlier
efforts,” Hoke said.
In addition to attracting public housing authorities,
property managers and owners, local health
departments and coalitions, and faith- and communitybased organizations from across Maryland and the
District of Columbia, the symposium also featured a
wide range of health and housing experts as speakers.
Professor Kathleen Hoke
Peter Ashley, DrPH, HUD’s director of Healthy
Homes and Lead Hazard Control, discussed the
As part of its mission to provide pro bono technical
agency’s role in overseeing public housing authorities
legal assistance on a wide range of public health
and federally subsidized properties, and promoting
issues, the Legal Resource Center for Public Health
healthier homes programs nationwide. He highlighted
Policy (LRC) at the University of Maryland Francis
King Carey School of Law is continually searching for economic, health, and safety reasons for HUD
proposing a rule that would require all public housing
ways to reach a broader variety of stakeholders.
authorities to prohibit smoking in individual units,
In June, the LRC co-hosted the Maryland Healthy
common areas, and within 25 feet of buildings.
Housing Symposium at Turf Valley Resort and
“Secondhand smoke has a lot of toxic and
Conference Center in suburban Baltimore. LRC
Director and Law School Professor Kathleen Hoke, JD carcinogenic chemicals, and it doesn’t stay only in the
’92, greeted approximately 100 federal, state, and local unit of the smoker in a multi-family property,” Ashley
said. “Also, tobacco smoking is an important safety
health and housing officials at the symposium, which
focused on challenges faced by vulnerable populations issue in that it is the major cause of fatal residential
fires.”
who live in substandard housing, increasing their
Cliff Mitchell, MS, MD, MPH, director of the
susceptibility to related illness and injury.
Environmental Health Bureau for the Maryland
The symposium topics included: the link between
Department of Health and Mental Hygiene (DHMH),
housing and health; the environmental exposures
which co-sponsored the symposium with Maryland
that affect individuals in the home (e.g. lead, radon,
Carey Law, spoke about the link between housing
mold, etc.); the impact smoking has on individuals
and emotional, mental, and physical health; the
living in multi-unit housing; and the U.S. Department
importance of providing healthy and safe living
of Housing and Urban Development’s (HUD)
proposed rule to prohibit smoking in public housing— spaces, particularly for vulnerable populations, such
as children; and the prominent role that communities
specifically, what it would mean for public housing
play in ensuring access to healthy and safe housing.
authorities and residents in Maryland.
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Meet Will Tilburg, the Legal Resource Center’s
Deputy Director

William Tilburg

Will Tilburg is the Deputy Director of the Legal Resource
Center for Public Health Policy and Senior Staff Attorney
with the Network for Public Health Law, Eastern Region,
both of which are located at Maryland Carey Law. Tilburg
graduated with honors from the law school in 2011 and
started working in both his current roles shortly after
graduation. He assists the Director of both programs,
Professor Kathleen Hoke, in their work with state and local
legislators, government attorneys, and health officials on
legal and policy issues related to public health. Tilburg
is also an adjunct professor at Maryland Carey Law and
University of Maryland School of Public Health, where he
teaches courses on health law and ethics, environmental
law, and oral advocacy. His focus areas include housing,
environmental health, medical marijuana, nutrition and
physical activity, and tobacco control. In June 2016,
Tilburg organized the Maryland Healthy Housing
Symposium mentioned in the prior article that brought
together 100 stakeholders to focus on challenges faced by
individuals living in substandard housing. In September,
he organized and moderated a panel at the National
Public Health Law Conference in Washington, DC called
“Efficient, Health and Safe Housing.” The session
examined innovative state and local policy interventions to
improve the housing situation of vulnerable populations.

Other speakers included LRC deputy director and
symposium organizer William Tilburg, JD ’11; Dana
Moncrief, MHS, CHES, chief, Statewide Public
Health Initiatives, DHMH; Tiffany Smith, MHSA,
from Howard County Housing; Tiffany Nicolette
from Shelter Properties, LLC; Laura Hale from the
American Lung Association; and Bob Vollinger,
MSPH, program director, Tobacco Control Research
Branch, National Institutes of Health.
“The speakers brought many different perspectives
to the discussion of ethical and effective methods
of assuring healthy housing for the least among us,”
said Hoke, who opened and closed the five-hour
symposium. “Simply gathering an eclectic group of
health and housing officials, offering various voices
and perspectives during the symposium, and allowing
for vigorous discussion created an environment rich
for further collaboration and cooperation. This cross-

cutting effort should result in comprehensive policy
options to reduce not only exposure to secondhand
smoke but also to other environmental hazards, such
as radon and mold.”
In addition to tobacco regulation and environmental
health, the LRC has been examining the public
health consequences of electronics; the medical use
of marijuana; and regulation of gambling hotline
ads. Hoke sees the Center playing an even greater
innovative role in the future.
“In collaboration with the Department of Health
and Mental Hygiene and Maryland’s 24 local health
departments, we are working to develop sound,
evidence-based policy options appropriate for state
and local governments and for public and private
housing. The Maryland Healthy Housing Symposium
took us another step along that path.”
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Law & Health Care Program Graduates 38 Students

2016 Health Law Certificate Graduates and L&HCP Faculty

At a gala celebration in May, Dean Donald Tobin,
L&HCP Director Diane Hoffmann, and L&HCP
faculty celebrated the success of health law certificate
students with their friends and family. The celebration
marked the 19th year of the certificate program. The
students were individually recognized by the faculty
who delivered personal comments about each of the
graduates before they got their certificate.
All of the program’s certificate students followed
different pathways determined by their particular
interest within health law. Some focused on mental
health issues, others on business aspects of the health
care industry and still others on public health law.
Below we share the pathways of several of our 2016
grads.
Vincent Andrews
Vincent graduated from Cornell University with
an undergraduate degree in Industrial and Labor
Relations in 2011 before coming to Maryland. While
in law school, Vincent externed at Care First Blue
Cross Blue Shield in their Office of General Counsel

where he worked on a wide range of issues including
a subscriber appeal before an Administrative Law
Judge and matters before the Maryland Insurance
Administration. His supervisor, Meredith Borden,
found him to be incredibly enthusiastic and eager
to learn about the business side of the health care
industry. Vincent wrote his Advanced Writing
Requirement Paper on the relationship between state
spending on mental health services for minors and
rates of juvenile incarceration. The paper looked at
how states interpreted and implemented SCHIP and
IDEA, which in turn affected state spending on mental
health services. Professor Diane Hoffmann, who was
his faculty advisor, said of the paper, “[i]t went far
beyond what I expected. While his legal research and
analysis were excellent and thorough, Vincent also
taught himself how to do multiple regression analysis
—no easy task!”   His enthusiasm and this experience
led to his selection as this year’s Business Fellow
at the University of Maryland Medical System’s in
house counsel’s office.   In this position, he assists
on a wide range of activities, from drafting physician
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employment contracts and lease arrangements to
analyzing patient care and Stark/anti-kickback issues.
An article about the Business Fellowship appears on
page 9 of this newsletter.

L&HCP Director Diane Hoffmann, 2016 Graduate Allison
Kronback and Prof. Ellen Weber (from l to r)

Monica Basche
Like many health law students who come to
Maryland Carey Law, Monica had health-related
experience in her background. As a Legal Marketing
Manager for Agora, a publishing and information
services company, she worked primarily with
clients in the dietary supplement industry, editing
their marketing materials and newsletters. At the
law school, Monica served as an executive articles
editor for the Maryland Law Review and research
assistant for Professor Donald Gifford in addition to
participating in a number of organizations, externing
at the Maryland Office of the Attorney General and
Food and Drug Administration, and engaging in
community service. Monica has chosen to pursue the
judicial clerkship route to prepare her for her career.
This year she will be clerking with Judge Adkins at the
Maryland Court of Appeals and in August 2017, will
start a two-year clerkship with Judge George Russell
at the U.S. District Court for the District of Maryland.
Describing her experience at the law school, Monica
said, “Maryland's Law and Health Care Program was
one of the most important parts of my law school
experience because it showed me how health law
intersects with so many different practice areas and
gave me access to externship opportunities that I
wouldn't have had anywhere else.”
Samantha Michelle Loh Collado
According to her mentor, L&HCP Professor
Richard Boldt, Samantha stood out as a law student
for multiple reasons—“she is serious, smart, and

incredibly well trained, but she is also optimistic,
kind and empathic in a way that is impossible not
to notice.” As Boldt’s research assistant, Samantha
helped with a project examining the outpatient
commitment of individuals with serious mental illness,
which resulted in the development of an article that
was published in the New England Law Review.
According to Boldt, “her investigation of state
statutes, funding mechanisms, and judicial opinions
in the area was detailed, thorough, and absolutely
essential to the overall project.” In addition, Samantha
served on the Executive Board of the Student Health
Law Organization, as managing editor of the Journal
of Health Care Law and Policy, and also competed
in both the Loyola Chicago National Health Law
Transactional Competition and the Maryland Health
Law Regulatory & Compliance Competition.
Samantha came to the law school with a public health
degree which helped her shine in Professor Weber’s
Drug Policy Clinic. Professor Weber reported that
her work on developing and drafting the Clinic’s
comments to proposed State regulations on the
certification of substance use treatment services
and their integration with mental health services
demonstrated the sort of methodical and thorough
research and analysis that few students could have
performed. Samantha is putting her health law and
policy degree to use as regulatory counsel at the
Center for Tobacco Control at FDA.

2016 Graduates Kelsey Harrer, Alexandria Montanio and
Samantha Collado (from l to r )

Alexandria Montanio
Alex graduated from University of Virginia in 2011
with High Distinction in Psychology and Distinction
in English. At the law school, she was equally as
distinguished. Alex was 11th in her class, a Leadership
Scholar, co-president of the winning Alternative
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Dispute Resolution Team and staff editor of the
Journal of Health Care Law and Policy. She also
externed at the Maryland Disability Law Center (now
Disability Rights Maryland) where she performed
site visits to programs to check for abuse and neglect
of vulnerable clients. Perhaps her most prominent
achievement in law school was being part of the
team that won the 5th Annual Health Law Regulatory
and Compliance Competition held at the law school.
This is the L&HCP’s own competition but, during
the first four years of the event, the Maryland team
never placed. In 2016 with Alex and two fellow
students, Maryland Carey Law brought home the big
plaque. Professor Frank Pasquale, faculty mentor
to the competition, said of Alex, “she is a brilliant
writer and thinker, also blessed with a great sense of
humor and perspective. She brought extraordinary
real-world experience to both my health law and
administrative law classes, and capped her career
here with a contribution to the emerging field of
algorithmic accountability. She uncovered problems in
organ allocation I was unaware of, and has developed
a clear regulatory proposal to address discrimination
against the disabled in that context.” Alex clerked at
Evergreen Health (Maryland’s only Health Care Co-op
created under the ACA and described on p. 9). She is
putting all this experience to work at Gordon Feinblatt
in their litigation and health care practices as a first
year associate.
Theresa Thompson
It’s hard to exaggerate Theresa’s commitment to
the Law & Health Care Program during her three
years at Maryland. She was the President of the
Student Health Law Organization (SHLO) for two
years, during which time the organization supported a
number of new and highly successful educational and
networking events. In particular, Theresa spearheaded
the Health Law Networking and Resume Review
Reception during which health law practitioners
review student resumes in advance and go over them
with students at a reception which also includes an
element of “speed networking.” In addition to her
activities with SHLO, Theresa was on the team with
Alex Montanio that won the Maryland Carey Law
Health Law Regulatory and Compliance Competition.
She also participated in the Loyola Chicago National
Health Law Transactional Competition. Finally,
she was manuscripts editor of the Journal of Health

Care Law & Policy, treasurer of the Women's Bar
Association, and a UMB President's Entrepreneurial
Fellow. She is now a first-year associate at Epstein
Becker Green in Washington and has promised to stay
involved as an alum for years to come.

L&HCP Director Diane Hoffmann, 2016 Graduate Michael
Vinluan and Prof. Richard Boldt (from l to r)

Michael Vinluan
Michael came to the law school with a medical
degree under his belt and prior to law school had
worked with the CDC, consulting with clinicians and
health departments across the United States on issues
including critical health threats, disease outbreaks,
and bioterrorism. His experience as a physician gave
Michael a unique and valuable perspective on the
topics raised in his health law courses—something
appreciated by his professors and fellow students.
Another way in which his medical background
privileged Michael was in the realm of externships.
He was able to secure multiple placements at
FDA. These externships led to a one-year Fellowship
in the FDA’s Office of the Commissioner. He also
served as a law clerk at Johns Hopkins Hospital in
their in-house counsel’s office. When each placement
ended, his supervisors asked him to stay on but
Michael was committed to finishing law school.
During law school, Michael worked as a consulting
medical expert for litigation law firms. He currently
works as a medical-legal consultant for law firms in
Washington, D.C. and Baltimore. According to his
mentor, Professor Richard Boldt, “Michael is just the
sort of person who makes our Law and Health Care
Program so fabulous. I expect to hear great things
about his work in the years to come, and I feel lucky
to have had the opportunity to be a part of his legal
education.”
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2016 health law certificate recipients
Samantha Altneu

Héctor Hernández

Julianna Kim

Siyang Song

Vince Andrews

Thomas Hoblitzell Jr.

Caroline Lee

Jenna Snyder

Loretta Bacon

Maryann Hong

Allison Kronback

Amethyst Spivak

Monica Basche

Diana-Lynne Hsu

Alexandria Montanio

Eric Suarez

Emilie Cobert

Minerva Hughes

Adetoro Olugbemi

Theresa Thompson

Samantha Collado

Megan Hurley

Maraya Pratt

Melissa View

Elizabeth De Santis

Sophia Jafrul

Heather Printz

Michael Vinluan

Apurva Dharia

Yevgeniya Kalinina

Amy Rappole

Sherri Weinstein

Alisha Duggal

Thomas Kandler

Ilan Roth

Kelsey Harrer

Alex Kelly

Gabriel Rubinstein

Third Annual Interprofessional Forum on Ethics and Religion in Health Care

CHALLENGES IN ORGAN DONATION &
TRANSPLANTATION
Tuesday, November 1, 2016
UMB’s Southern Management Corporation
Campus Center
621 W. Lombard St., Baltimore, MD
Presented by the University of Maryland Schools of Medicine, Nursing, Pharmacy, and
Social Work; the UMB Graduate School; the Maryland Healthcare Ethics Committee
Network at Maryland Carey Law; and the Institute for Jewish Continuity
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Hoffmann Selected to Serve on Composite
Committee for USMLE
Last spring,
Professor Diane
Hoffmann, director
of the Law & Health
Care Program at
Maryland Carey
Law, was asked by
the president of the
Federation of State
Medical Boards if
she would serve
on the Composite
Committee for the
United States Medical Licensing Exam (USMLE).
The USLME is the single pathway for licensure for all
medical school graduates (from schools in the U.S. as
well as other nations) who wish to practice allopathic
medicine in the U.S. The exam provides state
medical boards with information they need about the
competency of applicants for licensure in their state.
The Composite Committee is the governing board for
the USMLE program. It is “responsible for the overall
direction of the program identifying and approving
procedures for scoring and determining the pass/fail
standard, and all significant policies and procedures.”1
The committee is composed of representatives from
the Federation of State Medical Boards (FSMB),
the National Board of Medical Examiners (NBME),
the Educational Commission for Foreign Medical
Graduates (ECFMG) and the public. The FSMB, a
non-profit organization, represents the 70 medical
and osteopathic boards of the United States and its
Territories. The NBME, also a non-profit organization,
prepares exams and assessments for a number of
health professional groups and the ECFMG certifies
international medical graduates desiring to enter U.S.
graduate medical education.
All physicians who successfully completed medical
school and residency and became licensed to practice
medicine in the U.S. since the early 1990s have
taken the USMLE. The exam replaced the NBME
Part Examination Program and the Federation
Licensing Exam (FLEX). The exam includes three
standardized assessments called step exams. The
first step is typically taken by medical students after

their second year of medical school. It focuses on the
basic sciences and tests whether students understand
and are able to apply scientific principles that form
the foundation for the safe and competent practice of
medicine. Step 1 scores are often used by residency
programs in selecting graduating medical students.
Failure on Step 1 may prevent a student from moving
forward in the medical school curriculum from the
basic sciences to the clinical sciences curriculum.
Step 2 is divided into two parts, Clinical Knowledge
and Clinical Skills. Students must pass both parts in
order to receive their medical degree and to be granted
a temporary state license to practice during their first
year of residency training. Step 2 evaluates whether
a medical student or graduate can apply medical
knowledge, skills and understanding of clinical
science essential for providing medical care under
supervision. The first part of the exam is given as a
traditional exam; the second part, Clinical Skills, uses
standardized patients and focuses on a candidate’s
communication and problem-solving skills.
Step 3 is typically taken after the first year of
medical residency and in all states passage of step 3 is
required for permanent licensure. It assesses whether
applicants “can apply medical knowledge and their
understanding of biomedical and clinical science
essential for the unsupervised practice of medicine,
with emphasis on patient management in ambulatory
settings.”2
Hoffmann attended her first meeting of the
Composite Committee in June in Philadelphia and was
impressed by the dedication and commitment of its
members to ensure that the exam process is one that
well prepares individuals to practice medicine and
assures the public that their doctors have achieved a
minimum level of competency.
______________________
Who is USMLE? At www.usmle.org/about/
Federation of State Medical Boards and National Board
of Medical Examiners. United States Medical Licensing
Examination: Step 3 at www.usmle.org/step-3/
1
2
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The Affordable Care Act: Too Big to Fail?
October 20, 2016, 5:30-7:00 pm
University of Maryland Carey School of Law
Ceremonial Moot Court Room, First Floor
Open to Public, Reception to Follow
As the 2016 Presidential election nears, candidates on different sides of the aisle have very different views
of the future of the Affordable Care Act (ACA). Hillary Clinton wants to “defend and expand” the ACA and
make a “public” insurance option available to consumers. Donald Trump asserts that “on day one of the
Trump Administration, we will ask Congress to immediately deliver a full repeal of Obamacare.” Members
of Congress are equally split on the law’s future.
It has been over five years since the law was enacted. Who have been the winners and who have been
the losers under the most ambitious overhaul of the nation’s health care system since Medicare was created
in 1965? What is the future of the law if Clinton wins or if Trump wins? Is it too big to fail? Which
components of the ACA are at most risk with either candidate? This election panel will look back at the
history of the ACA but, more importantly, look forward to the program’s future with representatives from
government agencies, insurance agencies and consumer representatives.
Panelists
Leonardo Cuello, JD, Director, Health Policy, NHeLP
Elizabeth Milito, JD, Senior Executive Counsel at National Federation of Independent Business
Kimberly Robinson, JD, Partner, Funk & Bolton and Executive Director of the League of Life and Health
Insurers of Maryland
Beth Sammis, Adjunct Lecturer, Anne Arundel Community College and Board Member, Consumer Health
First (former Acting Insurance Commission for the State of Maryland)
Moderator
Diane E. Hoffmann, JD, MS, Professor of Law, Director, Law & Health Care Program University of
Maryland Carey School of Law
Sponsored by the Karen Rothenberg and Jeffrey Seltzer Law & Health Care Program Fund
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SAVE THE DATE
Zika Global to Local: Addressing the Epidemic from an
International and Interprofessional Lens

As the Zika virus moves deeper into North America,
different sectors of U.S. society are mobilizing to
address the epidemic by preventing the spread of
the virus, identifying patients, treating affected
individuals, and working toward a vaccine. Faculty
members at University of Maryland, Baltimore
(UMB) are on the front line of the fight against Zika
using their expertise to develop and refine the legal,
medical and regulatory tools needed to face a new
epidemic. How Zika is addressed in the U.S. and our
own community in Baltimore will be greatly informed
by the experience of countries in South and Central
America where the virus first emerged.
The Law & Health Care Program and the Center
for Global Education Initiatives is hosting a panel
on February 15, 2017 to learn about the Zika virus
from UMB faculty on the front lines of Zika research
as well as from the Costa Rican Ambassador to the
U.S. who brings his perspective as both a government
official in an affected country and a biotechnologist.
Join us at this informative public discussion.
Panelists
Dr. Roman Macaya, ambassador of Costa Rica to the
U.S. Ambassador Macaya has a
multidisciplinary background as a scientist,
businessman, advocate, politician, and academic. As
a chemist and biochemist by training, Ambassador
Macaya has led R&D teams in the fields of
biotechnology and biomedical research. The
Ambassador has authored numerous articles in
peer-reviewed journals in the life sciences and was
lead inventor on a patent application for a drug
candidate. As an Ambassador, Dr. Macaya has given
Science Diplomacy a high priority, an effort that has
yielded concrete results in science and technology
collaborations between the United States and Costa
Rica.

Professor Michael Greenberger, professor at
Maryland Carey Law and director of the University of
Maryland Center for Health and Homeland Security
(CHHS). Professor Greenberger and CHHS are
actively working with governmental clients to develop
plans on how to respond to emerging infectious
diseases, including Zika.
Professor Leslie Meltzer Henry, professor at
Maryland Carey Law. Professor Henry and colleagues
at other institutions were recently funded by the
Wellcome Trust to develop ethical and legal guidance
for conducting research with pregnant women during
public health emergencies, like the Zika crisis, where
there is an urgent need to attend to the health needs
of pregnant women and their offspring. The project
is called “Conducting Ethical Research with Pregnant
Women in the Emerging Zika Pandemic and Beyond:
Challenges Arising in Public Health Crises.”
Dr. Jon Mark Hirshon, professor in the Department
of Emergency Medicine and in the Department of
Epidemiology and Public Health at the University
of Maryland School of Medicine. He is the former
director of the Charles McC. Mathias, Jr. National
Study Center for Trauma and EMS and is currently the
senior vice-chairman of the University of Maryland,
Baltimore's IRB. Dr. Hirshon recently published
“Zika Virus: Critical Information for Emergency
Providers” with colleagues and, as a board member
of the American College of Emergency Physicians, is
working on the organization’s guidelines for the virus.
Dr. Kathleen Neuzil, director, Center for Vaccine
Development at University of Maryland School of
Medicine. The Center for Vaccine Development has
been chosen as one of three study sites in a human
safety trial of a new Zika vaccine. The early-stage
study will evaluate the experimental vaccine’s safety
and ability to generate an immune system response in
participants.

19 │ Law & Health Care Newsletter

Law & Health Care Program
500 West Baltimore Street
Baltimore, MD 21201
www.law.umaryland.edu/healthlaw
Comments and letters should be
forwarded to the above address.

Support the Law & Health Care Program
The Law & Health Care Program has hosted a number of hallmark meetings and roundtables to bring
together health care practitioners, legal academics, medical experts, scientists, and policymakers to
examine cutting-edge issues in health policy, law, or ethics. Over the next 30 years, we hope to count you
as a partner in this effort. We plan to build on the stellar foundation we have created as health law educators
to keep asking questions and pushing the field of health law forward. In order to do this, we are asking for
your support. Every contribution helps our program achieve its goals.
There are two ways to give to the Law & Health Care Program:
~ Online at http://www.law.umaryland.edu/give/healthlaw
~ Mail, by sending a check made payable to: UMBF, Inc./ Law & Health Care
to 620 West Lexington Street, 2nd Floor, Baltimore, MD 21201
Funds for the Law & Health Care Program are administered by the University of Maryland, Baltimore Foundation, Inc.
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